CAS 794568-92-6 appears in our catalog under these names: BAY 73-6691, 98%, BAY 73–6691 ((R)–BAY 73–6691), BAY 73-6691, BAY 73-6691, 99.84%, BAY 73-6691 >= 98 % HPLC, powder. Offered by: AmBeed, GLPBio, Biosynth, MedChemExpress, Sigma-Aldrich. Available pack sizes: 100mg, 10mg, 25mg, 5mg, 50mg, 100 mg, 50 mg, 25 mg.
BAY 73-6691 is a member of the class of pyrazolopyrimidines that is 4,5-dihydro-1H-pyrazolo[3,4-d]pyrimidine substituted by 2-chlorophenyl, oxo, and (2R)-3,3,3-trifluoro-2-methylpropyl groups at positions 1, 4 and 6, respectively. It is a potent and selective inhibitor of phosphodiesterase 9 (PDE9), currently in pre-clinical development for the treatment of Alzheimer's disease. It has a role as an EC 3.1.4.* (phosphoric diester hydrolase) inhibitor, a neuroprotective agent, a nootropic agent and an apoptosis inducer. It is an organofluorine compound, a pyrazolopyrimidine and a member of monochlorobenzenes.
Source: ChEBI
| Molecular formula | C15H12ClF3N4O |
|---|---|
| Molecular weight | 356.73 g/mol |
| IUPAC name | 1-(2-chlorophenyl)-6-[(2R)-3,3,3-trifluoro-2-methylpropyl]-5H-pyrazolo[5,4-d]pyrimidin-4-one |
| InChIKey | FFPXPXOAFQCNBS-MRVPVSSYSA-N |
| SMILES | C[C@H](CC1=NC2=C(C=NN2C3=CC=CC=C3Cl)C(=O)N1)C(F)(F)F |
Computed by PubChem (NCBI)